Launches of complexes and generics is about to change the statin market

‘Lipitor (atorvastatin)’ and ‘Crestor (generic name: rosuvastatin)’, which have divided the hyperlipidemia treatment market into tow, encountered the situation to defend attacks of complexes and generics this year and next year, respectively.

Although they already have experienced the burst of generics after their patent expirations, the pharmaceutical industry doubt that the new situation is ...